\begin{tabular}{lllll}
Rank & Score & Pair & Description & NN \\
\hline
\bfseries 1 & \bfseries 0.392 & \bfseries D00283 & \bfseries Clozapine & 0.769 \\
\bfseries\indb{C,D}   &    & \bfseries hsa1814 & \bfseries DRD3: dopamine receptor D3 & 0.455 \\
\hline
\bfseries 2 & \bfseries 0.300 & \bfseries D02358 & \bfseries Metoprolol & 0.750 \\
\bfseries\indb{C,D}   &    & \bfseries hsa154 & \bfseries ADRB2: beta-2 adrenergic receptor & 0.434 \\
\hline
 3 &  0.299 &  D00604 &  Clonidine hydrochloride & 0.933 \\
   &    &  hsa147 &  ADRA1B: alpha-1B adrenergic receptor & 0.435 \\
\hline
 4 &  0.294 &  D03966 &  Eglumegad & 0.036 \\
   &    &  hsa2914 &  GRM4: glutamate receptor, metabotropic 4 & 0.768 \\
\hline
 5 &  0.292 &  D00255 &  Carvedilol & 0.380 \\
   &    &  hsa152 &  ADRA2C: alpha-2C adrenergic receptor & 0.489 \\
\hline
\bfseries 6 & \bfseries 0.291 & \bfseries D04625 & \bfseries Isoetharine & 0.737 \\
\bfseries\indb{K}   &    & \bfseries hsa154 & \bfseries ADRB2: beta-2 adrenergic receptor & 0.434 \\
\hline
 7 &  0.289 &  D03966 &  Eglumegad & 0.036 \\
   &    &  hsa2917 &  GRM7: glutamate receptor, metabotropic 7 & 0.758 \\
\hline
\bfseries 8 & \bfseries 0.288 & \bfseries D02340 & \bfseries Loxapine & 0.769 \\
\bfseries\indb{D}   &    & \bfseries hsa1812 & \bfseries DRD1: dopamine receptor D1 & 0.205 \\
\hline
 9 &  0.288 &  D00503 &  Perphenazine & 0.857 \\
   &    &  hsa1816 &  DRD5: dopamine receptor D5 & 0.529 \\
\hline
 10 &  0.270 &  D00682 &  Carboprost tromethamine & 0.914 \\
   &    &  hsa5739 &  PTGIR: prostaglandin I2 receptor (IP) & 0.150 \\
\hline
 11 &  0.268 &  D01973 &  Eletriptan hydrobromide & 0.417 \\
   &    &  hsa3361 &  HTR5A: 5-hydroxytryptamine (serotonin) receptor 5A & 0.304 \\
\hline
\bfseries 12 & \bfseries 0.262 & \bfseries D00790 & \bfseries Chlorprothixene & 0.826 \\
\bfseries\indb{D}   &    & \bfseries hsa1814 & \bfseries DRD3: dopamine receptor D3 & 0.455 \\
\hline
 13 &  0.260 &  D00503 &  Perphenazine & 0.857 \\
   &    &  hsa3356 &  HTR2A: 5-hydroxytryptamine (serotonin) receptor 2A & 0.186 \\
\hline
\bfseries 14 & \bfseries 0.260 & \bfseries D00079 & \bfseries Dinoprostone & 0.852 \\
\bfseries\indb{C,D}   &    & \bfseries hsa5731 & \bfseries PTGER1: prostaglandin E receptor 1 (subtype EP1), 42kDa & 0.150 \\
\hline
 15 &  0.257 &  D02884 &  Ambuphylline & 0.650 \\
   &    &  hsa140 &  ADORA3: adenosine A3 receptor & 0.477 \\
\hline
\bfseries 16 & \bfseries 0.256 & \bfseries D02250 & \bfseries Octreotide acetate & 0.759 \\
\bfseries\indb{K}   &    & \bfseries hsa6751 & \bfseries SSTR1: somatostatin receptor 1 & 0.456 \\
\hline
 17 &  0.251 &  D02354 &  Thiethylperazine & 0.793 \\
   &    &  hsa1814 &  DRD3: dopamine receptor D3 & 0.455 \\
\hline
\bfseries 18 & \bfseries 0.250 & \bfseries D05113 & \bfseries Naltrexone & 0.714 \\
\bfseries\indb{C,D}   &    & \bfseries hsa4986 & \bfseries OPRK1: opioid receptor, kappa 1 & 0.563 \\
\hline
 19 &  0.248 &  D01712 &  Theophylline sodium acetate & 0.684 \\
   &    &  hsa140 &  ADORA3: adenosine A3 receptor & 0.477 \\
\hline
\bfseries 20 & \bfseries 0.246 & \bfseries D00095 & \bfseries Epinephrine & 0.929 \\
\bfseries\indb{C,K}   &    & \bfseries hsa155 & \bfseries ADRB3: beta-3 adrenergic receptor & 0.423 \\
\hline
\end{tabular}
